Current landscape and emerging opportunities for using telecytology for rapid on-site assessment in cytopathology
- PMID: 40522771
- PMCID: PMC12169389
- DOI: 10.1002/cncy.70027
Current landscape and emerging opportunities for using telecytology for rapid on-site assessment in cytopathology
Abstract
In recent years, cytopathology practices increasingly are considering the adoption of digital modalities to support remote rapid on-site evaluation (ROSE) of fine-needle aspiration biopsies. Currently, various digital options are available, each of which has unique advantages and limitations. This review covers all relevant aspects of telecytology for ROSE, including digital pathology options, operators, validation, quality assurance, reimbursement, and recommendations from professional organizations. The evolving landscape of telecytology for ROSE, including the development of devices for standardized specimen preparation and staining, next-generation digital microscopy techniques, and deep-learning-based artificial intelligence tools as decision-support aids for the interpretation of digital images, also is outlined.
Keywords: artificial intelligence (AI); digital cytopathology; digital microscopy; rapid on‐site evaluation (ROSE); telecytology.
© 2025 The Author(s). Cancer Cytopathology published by Wiley Periodicals LLC on behalf of American Cancer Society.
Conflict of interest statement
Savitri Krishnamurthy reports personal/consulting fees from ASP Health outside the submitted work.
Figures



Similar articles
-
Telecytology and its evolving role in cytopathology.Diagn Cytopathol. 2012 Jun;40(6):498-502. doi: 10.1002/dc.22822. Diagn Cytopathol. 2012. PMID: 22619124 Review.
-
Rapid on-site evaluation using telecytology: Quality assurance study at a high-volume cancer center.Cancer Cytopathol. 2025 Jan;133(1):e22929. doi: 10.1002/cncy.22929. Cancer Cytopathol. 2025. PMID: 39745134 Free PMC article.
-
American Society of Cytopathology Telecytology validation recommendations for rapid on-site evaluation (ROSE).J Am Soc Cytopathol. 2024 Mar-Apr;13(2):111-121. doi: 10.1016/j.jasc.2023.12.001. Epub 2023 Dec 9. J Am Soc Cytopathol. 2024. PMID: 38310002 Review.
-
International telecytology: Current applications and future potential.Diagn Cytopathol. 2019 Jan;47(1):28-34. doi: 10.1002/dc.23960. Epub 2018 May 4. Diagn Cytopathol. 2019. PMID: 29727061 Review.
-
Telecytology validation: is there a recipe for everybody?J Am Soc Cytopathol. 2022 Jul-Aug;11(4):218-225. doi: 10.1016/j.jasc.2022.03.001. Epub 2022 Mar 10. J Am Soc Cytopathol. 2022. PMID: 35469774
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical